基于伊米达佐利丁的酸盐抑制剂用于氏菌感染
B Bindu1, A Manikandan2, S Jeevitha2
1Department of Chemistry, Government Arts College, Coimbatore, India.
Drug development research
|March 31, 2025
概括
新的伊米达佐利丁衍生物通过抑制关键的阿斯帕尔特蛋白酶显示出强大的抗真菌活性,对抗坎迪达菌种类. 化合物5g,5h和5j是进一步临床前开发抗候群病的有希望的候选物.
科学领域:
- 药用化学 医学化学
- 菌类学 菌类学是指菌类学.
- 生物化学 生物化学
背景情况:
- 真菌感染,特别是由Candida物种引起的疹病,构成了全球重大健康威胁.
- 坎迪达阿尔比坎斯 (Candida Albicans) 分泌阿斯巴达蛋白酶 (Saps),这是关键的毒性因子,涉及真菌生理学和宿主-病原体相互作用.
研究的目的:
- 研究新型含硫烯的伊米达索利丁衍生物作为抗候群剂的潜力.
- 为了评估这些化合物对Candida Albicans酸蛋白酶 (Saps) 的抑制.
主要方法:
- 合成和描述12个含硫烯的伊米达索利丁化合物 (5a-l).
- 在体外评估抗甘地达活性和阿斯巴拉特蛋白酶抑制.
- 在基分子对接研究中验证酶抑制相互作用.
主要成果:
- 所有测试的伊米达索利丁衍生物 (5a-l) 都显示抑制了真菌酸蛋白酶.
- 化合物表现出显著的抗候群活性.
- 伊米达佐利丁衍生物5g,5h和5j被确定为最强大的抗真菌剂.
结论:
- 含有硫烯的伊米达索利丁是Candida亚斯巴达蛋白酶的有效抑制剂.
- 鉴定到的强效化合物 (5g,5h,5j) 值得进一步进行临床前研究,以治疗白病.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


